Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria

id	metarevistapublica_fucsalud_revistarepertoriodemedicinaycirugia_98-article-1472
record_format	ojs
spelling	Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria Revista Repertorio de Medicina y Cirugía Núm. 2 , Año 2025 : mayo - agosto 2 34 García, Greysy Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Artículo de revista Fierro , Luis Felipe García , Andrés Felipe Buitrago Gómez, Nathalia López, Laura Rueda , María Fernanda Moreno, Marcia Journal article Biagetti B, Ferrer R, Alfayate R, Álvarez E, Berlanga E, Casals G, et al. Macroprolactina: del laboratorio a la práctica clínica. Recomendaciones del grupo de trabajo de laboratorio de la SEEN y de la comisión de hormonas de la SEQCML sobre la medición e informe del resultado de la macrop. Endocrinol Diabetes y Nutr. 2022;69(1):63–9. https://doi.org/10.1016/j.endinu.2020.12.002 Rodier C, Courbière B, Fernandes S, Vermalle M, Florence B, Resseguier N, et al. Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles? Front Endocrinol (Lausanne). 2022;13:832361. https://doi.org/10.3389/fendo.2022.832361 Davoudi Z, Araghi F, Vahedi M, Mokhtari N, Gheisari M. Prolactin level in polycystic ovary syndrome (Pcos): An approach to the diagnosis and management. Acta Biomed. 2021;92(5):e2021291. https://doi.org/10.23750/abm.v92i5.9866 Hamed EA, Sayyed HG, Abbas AM, Gaber MMA, El Aleem HMA. Nesfatin-1, Dopamine, and NADPH levels in Infertile Women with Polycystic Ovary Syndrome: Is There a Relationship Between Their Levels and Metabolic and Hormonal Variables. J Reprod Infertil. 2022;23(3):160–8. https://doi.org/10.18502/jri.v23i3.10006 Ntali G, Wass JA. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary. 2018;21(2):111–8. http://dx.doi.org/10.1007/s11102-018-0869-3 Navy H, Gardner K. Strategies for managing medication-induced hyperprolactinemia. Curr Psychiatr. 2018;17(3):42–6. Mana DL, Danilowicz K, Rizzo LFL. Impacto de la prolactina en psiquiatría. Separata. 2021;29(6):1–36. Morandi Stumpf MA, Pinheiro FMM, Silva GO, Cescato VAS, Musolino NRC, Cunha-Neto MBC, et al. How to manage intolerance to dopamine agonist in patients with prolactinoma. Pituitary. 2023;26(2):187–96. https://doi.org/10.1007/s11102-023-01313-8 Thapa S, Bhusal K. Hyperprolactinemia. In: StatPearls [Internet]. 2022. p.1–16. Samperi I, Lithgow K, Karavitaki N. Hyperprolactinaemia. J Clin Med. 2019;8(12):2203. https://doi.org/10.3390/jcm8122203 Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M, et al. Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur J Endocrinol. 2022;186(3):P1–P33. https://doi.org/10.1530/EJE-21-0977 Vilar L, Vilar F, Freitas C. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia. 2019;109(1):7–19. https://doi.org/10.1159/000499694 Matalliotakis M, Koliarakis I, Matalliotaki C, Trivli A, Hatzidaki E. Clinical manifestations, evaluation and management of hyperprolactinemia in adolescent and young girls: a brief review. Acta Biomed. 2019;90(1):149-157. https://doi.org/10.23750/abm.v90i1.8142 Chen AX, Burt MG. Hyperprolactinaemia. Aust Prescr. 2017;40(6):220-224. https://doi.org/10.18773/austprescr.2017.060 Niculescu DA, Gheorghiu ML, Poiana C. Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile? Eur J Endocrinol. 2023;188(4):R88–97. https://doi.org/10.1093/ejendo/lvad044 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1472/2870 Budayr A, Tan TC, Lo JC, Zaroff JG, Tabada GH, Yang J, et al. Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: The CATCH study. BMC Endocr Disord. 2020;20(1):25. https://doi.org/10.1186/s12902-020-0507-8 http://purl.org/coar/resource_type/c_dcae04bc Text http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/publishedVersion http://purl.org/redcol/resource_type/ARTREV http://purl.org/coar/resource_type/c_6501 Steeds RP, Stiles CE, Sharma V, Chambers JB, Lloyd G, Drake W. Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. Echo Res Pract. 2019;6(1):G1–G8. https://doi.org/10.1530/ERP-18-0069 info:eu-repo/semantics/article https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1472/2895 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1472/2879 Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R. Approach to the Patient With Prolactinoma. J Clin Endocrinol Metab. 2023;108(9):2400-2423. https://doi.org/10.1210/clinem/dgad174 Krysiak R, Kowalcze K, Okopień B. Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: A pilot study. Endocrinol Diabetes y Nutr. 2022;69(4):279–88. https://doi.org/10.1016/j.endien.2021.03.004 Krysiak R, Kowalcze K, Okopień B. Sexual function and depressive symptoms in young women with hypoprolactinaemia. Clin Endocrinol (Oxf). 2020;93(4):482–488. https://doi.org/10.1111/cen.14283 Glezer A, Bronstein MD. Hyperprolactinemia. 2022 Jan 5. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000. Bernard V, Young J, Binart N. Prolactin — a pleiotropic factor in health and disease. Nat Rev Endocrinol. 2019;15(6):356–65. http://dx.doi.org/10.1038/s41574-019-0194-6 Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–88. https://doi.org/10.1210/jc.2010-1692 diagnosis text/xml text/html application/pdf 2025-05-15 2025-05-15 17:55:08 2025-05-15 17:55:08 cabergoline 2462-991X hyperprolactinemia prolactine diagnóstico cabergolina hiperprolactinemia prolactina 0121-7372 https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1472 Abreu-Lomba A, Buitrago-Gómez N, Zambrano-Urbano J, Bedoya-Joaqui V, Osorio-Correa V, Velásquez PA, et al. Presentación clínica y respuesta al tratamiento de macroprolactinomas invasivos en mujeres. Cali-Colombia. Rev Argent Endocrinol Metab. 2020;57(3):13–21. Vilar L, Vilar CF, Lyra R, Freitas MDC. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia. Neuroendocrinology. 2019;109(1):7-19. http://dx.doi.org/10.1159/000499694 Lau C, Aw T. A Current Approach to Hyperprolactinemia. Int Arch Endocrinol Clin Res. 2019;5(1):1–8. https://doi.org/10.23937/2572-407X.1510018 Zou Y, Li D, Gu J, Chen S, Wen X, Dong J, et al. The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis. BMC Endocr Disord. 2021;21(1):225. https://doi.org/10.1186/s12902-021-00889-1 Huang W, Molitch ME. Prolactin and Other Pituitary Disorders in Kidney Disease. Semin Nephrol. 2021;41(2):156–67. https://doi.org/10.1016/j.semnephrol.2021.03.010 Levine S, Muneyyirci-Delale O. Stress-induced hyperprolactinemia: Pathophysiology and clinical approach. Obstet Gynecol Int. 2018;2018:9253083. http://dx.doi.org/10.1155/2018/9253083 Cidade-Rodrigues C, Cunha FM, Chaves C, Silva-Vieira M, Silva A, Garrido S, et al. The utility of prolactin serial sampling and the best prolactin cut-offs associated with persistent hyperprolactinemia. Porto Biomed J. 2021;6(2):e133. http://dx.doi.org/10.1097/j.pbj.0000000000000133 Kaiser U, Ho YKEN. Fisiología y evaluación diagnóstica de la hipófisis. En: Melmed S, Auchus RJ, Rosen CJ. Williams Tratado de endocrinología 14th Ed. Elsevier; 2022. p.184–235. http://dx.doi.org/10.1016/B978-84-9113-851-8/00008-0 119 10.31260/RepertMedCir.01217372.1472 113 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Revista Repertorio de Medicina y Cirugía - 2025 https://creativecommons.org/licenses/by-nc-sa/4.0 https://doi.org/10.31260/RepertMedCir.01217372.1472 Publication
institution	FUNDACIÓN UNIVERSITARIA DE CIENCIA DE LA SALUD
thumbnail	https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIADECIENCIADELASALUD/logo.png
country_str	Colombia
collection	Revista Repertorio de Medicina y Cirugía
title	Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria
spellingShingle	Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria García, Greysy Fierro , Luis Felipe García , Andrés Felipe Buitrago Gómez, Nathalia López, Laura Rueda , María Fernanda Moreno, Marcia diagnosis cabergoline hyperprolactinemia prolactine diagnóstico cabergolina hiperprolactinemia prolactina
title_short	Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria
title_full	Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria
title_fullStr	Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria
title_full_unstemmed	Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria
title_sort	enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria
author	García, Greysy Fierro , Luis Felipe García , Andrés Felipe Buitrago Gómez, Nathalia López, Laura Rueda , María Fernanda Moreno, Marcia
author_facet	García, Greysy Fierro , Luis Felipe García , Andrés Felipe Buitrago Gómez, Nathalia López, Laura Rueda , María Fernanda Moreno, Marcia
topic	diagnosis cabergoline hyperprolactinemia prolactine diagnóstico cabergolina hiperprolactinemia prolactina
topic_facet	diagnosis cabergoline hyperprolactinemia prolactine diagnóstico cabergolina hiperprolactinemia prolactina
citationvolume	34
citationissue	2
citationedition	Núm. 2 , Año 2025 : mayo - agosto
publisher	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
ispartofjournal	Revista Repertorio de Medicina y Cirugía
source	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1472
language
format	Article
rights	http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Revista Repertorio de Medicina y Cirugía - 2025 https://creativecommons.org/licenses/by-nc-sa/4.0
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_dcae04bc
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2025-05-15
date_accessioned	2025-05-15 17:55:08
date_available	2025-05-15 17:55:08
url	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1472
url_doi	https://doi.org/10.31260/RepertMedCir.01217372.1472
issn	0121-7372
eissn	2462-991X
doi	10.31260/RepertMedCir.01217372.1472
citationstartpage	113
citationendpage	119
url2_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1472/2870
url4_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1472/2895
url3_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1472/2879
_version_	1833615060432322560

Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria .

Código QR

Estadísticas y Métricas Alternativas

Títulos similares

Enfoque diagnóstico y tratamiento de hiperprolactinemia en la atención primaria
.